STAAR Surgical (STAA) Cash Flow Statement

Click line-items for a historical chart and %

Net income	-11.96M
Income from discontinued operations
Depreciation of property and equipment	1.93M
Amortization of intangibles	171K
Amortization of discount
Loss on early extinguishment of note payable
Deferred income taxes	-1.81M
Fair value adjustment of warrant
Loss (gain) on disposal of property and equipment
Change in net pension liability	390K
Stock-based compensation expense	8.14M
Other
Accounts receivable	1.71M
Inventories	1.6M
Prepaids, deposits and other current assets
Accounts payable	594K
Other current liabilities	1.1M
Net cash used in operating activities of discontinued operations
Net cash provided by (used in) operating activities
Proceeds from sale of subsidiary, net of transaction costs
Release of restricted cash
Deposit to restricted escrow account
Acquisition of property and equipment	-2.71M
Proceeds from sale of property and equipment	65K
Net change in other assets
Net cash used in investing activities of discontinued operations
Net cash provided by (used in) investing activities
Repayment of notes payable
Redemption of Series A preferred stock
Repayment of capital lease obligations	-302K
Proceeds from exercise of stock options	1.65M
Net cash used in financing activities of discontinued operations
Net cash provided by (used in) financing activities
Effect of exchange rate changes on cash and cash equivalents	777K
Increase in cash and cash equivalents	882K
Cash and cash equivalents, at beginning of the period	13.4M
Cash and cash equivalents, at end of the period	14.28M

Entities mentioned with STAA

View All Entities